Prevalence and associated factors of medication non-adherence in hematological-oncological patients in their home situation
Abstract Background Medication non-adherence is associated with poor health outcomes and increased health care costs. Depending on definitions, reported non-adherence rates in cancer patients ranges between 16 and 100%, which illustrates a serious problem. In malignancy, non-adherence reduces chance...
Main Authors: | Linda Bouwman, Corien M. Eeltink, Otto Visser, Jeroen J. W. M. Janssen, Jolanda M. Maaskant |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-11-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-017-3735-1 |
Similar Items
-
Emerging Role of Biosimilars in Oncology-Hematology in Saudi Arabia: A Practical Perspective
by: Mansoor A. Khan, et al.
Published: (2020-02-01) -
Intestinal barrier functions in hematologic and oncologic diseases
by: Elio Haroun, et al.
Published: (2023-03-01) -
A cancer disparities curriculum in a hematology/oncology fellowship program
by: Marium Husain, et al.
Published: (2023-10-01) -
The Expanding Role of the Oncology Pharmacist
by: Lisa M. Holle, et al.
Published: (2020-07-01) -
Awareness of the impact of sex and gender in the disease risk and outcomes in hematology and medical oncology—a survey of Swiss clinicians
by: Xenia Darphin, et al.
Published: (2024-02-01)